API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/tolero-pharmaceuticals-presents-biomarker-identification-strategies-for-investigational-agents-alvocidib-and-tp-1287-at-aacr-virtual-meeting-ii-2020-301080619.html
https://www.prnewswire.com/news-releases/tolero-pharmaceuticals-presents-findings-from-phase-1-zella-101-clinical-study-evaluating-investigational-agent-alvocidib-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-at-virtual-eha-annual-congress-2020-301074874.html
https://www.prnewswire.com/news-releases/tolero-pharmaceuticals-announces-first-patient-dosed-in-phase-2-zella-202-study-of-investigational-agent-alvocidib-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-following-treatment-with-venetoclax-and-hma-combinat-300987212.html
https://www.fiercebiotech.com/biotech/abbvie-tolero-team-up-to-test-venclexta-combo-aml
http://www.biospace.com/News/tolero-pharmaceuticals-receives-european-medicines/366271/source=MoreNews